Skip to content
Lower risk Medical device recall · FDA · Published September 5, 2018

BioFire FilmArray Blood Culture Kit False Positive Risk with Specific Bottles

BioFire Diagnostics recalls FilmArray Blood Culture Identification kits that may give false positive results for Proteus when used with certain blood culture bottles. Affected kits include specific catalog numbers and bottle types.

🇺🇸 FDA recall #Z-0296-2019Medical deviceBioFire Diagnostics ›
Take action

Contact the company

Recalling firmBioFire Diagnostics, LLC515 S Colorow Dr · Salt Lake City, UT 84108-1248
✎ GovInfoNow plain-language explainer

What happened, in plain English

BioFire Diagnostics is recalling some FilmArray Blood Culture Identification kits because they can produce false positive results for Proteus when used with specific blood culture bottles. This could lead to incorrect diagnoses and unnecessary treatments. Read more at govinfonow.com/recall/69909-biofire-filmarray-blood-culture-kit-false-positive-risk-with-specific.

Source Summary by GovInfoNow · govinfonow.com/recall/69909-biofire-filmarray-blood-culture-kit-false-positive-risk-with-specific · Updated August 20, 2026 · FDA enforcement record: FDA #Z-0296-2019

Cite this page

“BioFire FilmArray Blood Culture Kit False Positive Risk with Specific Bottles.” GovInfoNow, updated August 20, 2026. https://govinfonow.com/recall/69909-biofire-filmarray-blood-culture-kit-false-positive-risk-with-specific. Based on FDA recall #Z-0296-2019 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0296-2019%22&limit=1).

Why it’s dangerous

The FilmArray kits can give false positive results for Proteus bacteria when used with specific blood culture bottles (BACT/ALERT FA Plus, FN Plus, or PF Plus). This means tests might incorrectly indicate Proteus infection when there isn't one, potentially leading to unnecessary treatments.

Who’s affected

Healthcare facilities using the recalled FilmArray Blood Culture Identification kits with the listed blood culture bottles are most at risk. Patients receiving blood cultures with these kits may be affected if the false positive results lead to incorrect treatment.

How to tell if you have this one

Check if your FilmArray Blood Culture Identification kit has catalog numbers RFIT-ASY-0126 (30 tests) or RFIT-ASY-0127 (6 tests). Also, verify if you're using the BACT/ALERT FA Plus (410851), FN Plus (410852), or PF Plus (410853) blood culture bottles.

  • Brand
    BioFire Diagnostics
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Kit Catalog Number

    Identify if your FilmArray Blood Culture Identification kit has catalog numbers RFIT-ASY-0126 (30 test kit) or RFIT-ASY-0127 (6 test kit).

  2. Verify Blood Culture Bottles

    Confirm if you're using BACT/ALERT FA Plus (410851), FN Plus (410852), or PF Plus (410853) blood culture bottles.

Where it went and when

Where it was distributed

Distributed nationwide, and outside the U.S.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Worldwide distribution. US nationwide, Kuwait, Lebanon, Malaysia, Myanmar, Nicaragua, Oman, Panama, Paraguay, Peru, Philippines, Qatar, Romania, Saudi Arabia, Slovenia, Uruguay, United Arab Emirates, Vietnam” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide, and outside the U.S.

Recall timeline

FDA terminated this recall 2.5 years after the firm started it.

1. Firm started the recall: Sep 5, 201812. FDA classified it Class II: Oct 30, 201823. Published in FDA’s Enforcement Report: Nov 7, 201834. FDA terminated the recall: Mar 22, 2021420182021
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Do I need to stop using the kits immediately?

No, but you should check if your kit and bottles match the recalled items before using them. The recall does not require immediate discontinuation.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-0296-2019 (September 5, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0296-2019 to see it in context.
  • Plain-language summary written by qwen3:4b on August 20, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA